Robert O'Dea Email & Phone Number

Consultant provides support for early (Phase 1 and 2a) clinical drug development for both small and large pharmaceutical companies. This includes special expertise in designing and completing MTD trials with complex adaptive designs, including semi-intensive QTc monitoring, SD / MD PK assessments and safety monitoring. Consultant also has extensive.

Minneapolis, MN

Support for first-year medical education as volunteer course participant in Medical Pharmacology, lecturing on drug-drug interactions and therapeutics in special populations. As a board-certified pediatrician, consultant has extensive experience with drug usage in the newborn and biochemical genetic / metabolic disease populations.

During an 11-year tenure at Abbott, consultant provided early drug development expertise as both PI and sub-PI for numerous Phase I trials and ultimately, as Director of Abbott Global Clinical Pharmacology. In addition to his managerial and scientific leadership in clinical pharmacology, he directed and re-organized a unique fellowship program in which.

Minneapolis, MN

Holding a joint appointment in two medical school departments, consultant ran a NIH-funded research laboratory investigating signal- transduction in neural cell systems. He also provided full-time support to the newborn medicine, metabolic disease and clinical pharmacology clinical services and contributed substantial effort to the pharmacology educational.

Clinical Pharmacology Fellowship

Pharmacology / Toxicology Program

Consultant was accepted into this prestigious training program at the NIH as a post-doctoral fellow. His research focused upon the.

Pediatrics Residency Program

Phd - Md, Pharmacology And Pediatrics

Activities and Societies: MD - PhD program

Bachelor'S Degree, Biology / Chemistry

Activities and Societies: Egregia cum laude graduate in Honors Program